Drugstores Report Increased Prescriptions for Medicare Obesity Drug Program

Why it matters locally: The Medicare Bridge program's expansion of obesity drug access could impact a significant number of Washington's Medicare beneficiaries, offering them new options for weight management through participating pharmacies. This federal initiative directly affects healthcare access and costs for eligible seniors and individuals with disabilities across the state.

Drugstore chains CVS and Walgreens have each dispensed 100,000 prescriptions under a new Medicare initiative. The program, known as Bridge, launched on July 1. It provides certain Medicare beneficiaries access to obesity medications for a monthly cost of $50. The Bridge program aims to increase access to specific obesity drugs for eligible Medicare participants. CVS and Walgreens began processing these prescriptions shortly after the program's implementation.